Skip to Main Content

For further information, see CMDT Part 32-05: Other Systemic Viral Diseases

Key Features

Essentials of Diagnosis

  • Most infected persons asymptomatically seroconvert

  • Clinical symptoms are akin to those of chikungunya virus infection but with less arthritis

  • Complications include microcephalic infants and ocular complications born to mothers infected during pregnancy as well as Guillain-Barré

  • There is no effective antiviral or vaccine

General Considerations

  • Zika virus is a flavivirus, akin to the viruses that cause dengue fever, Japanese encephalitis, and West Nile infection

  • Aedes species mosquitoes, particularly Aedes aegypti, are responsible for transmission of Zika virus

  • The biodistribution of the species largely determines the area of prevalence for Zika virus

  • Aedes species mosquitoes are found primarily in the southeastern United States, but one species Aedes albopictus (the Asian tiger mosquito known to sequester in tires) may be seen as far north as Pennsylvania

  • Modes of transmission

    • Sexual: reported from males and females to partners via vaginal, anal, or oral sex

    • Vertical: from pregnant woman to fetus is prominent

    • Via platelet transfusion has also been reported

Demographics

  • The virus was noted in Africa and Asia during the 1950s–1980s

  • A large outbreak occurred in French Polynesia in 2013

  • A smaller outbreak occurred on Easter Island during 2014

  • Noted in Brazil in 2015; up to 1.3 million cases during that year

  • Cases have been documented in California, New York, Florida, and Texas

Clinical Findings

Symptoms and Signs

  • Incubation period is about 10 days

  • Most infections are asymptomatic

  • Acute onset fever

  • Maculopapular rash that is often pruritic

  • Nonpurulent conjunctivitis

  • Arthralgias

  • Rash may outlast the fever but is not always present

  • Symptoms last up to 7 days

Differential Diagnosis

  • Dengue

  • Chikungunya virus infection

Diagnosis

  • The CDC recommends that everyone with symptoms of Zika infection be tested if they have traveled to an endemic area with active transmission as well as all pregnant women who have lived or visited affected regions

  • Diagnosis is made by detecting viral RNA or neutralizing antibody, IgM 4 days or more after symptom onset or IgG after 7 days or more

  • Reverse transcriptase polymerase chain reaction (RT-PCR) detects the virus in blood or urine and should be performed within 2 weeks of illness onset

  • Matched serum and urine specimens should be tested simultaneously

Treatment

  • There are no effective antivirals against Zika virus

  • Sofosbuvir

    • Shows some ability to inhibit Zika replication and infection in vitro

    • Appears to be synergistic with interferon-α and with interferon-β

  • Aspirin does not appear to be associated with major hemorrhagic complications as seen in dengue

Outcome

Complications

  • Congenital microcephaly

  • Ocular findings, including focal macular pigment mottling, chorioretinal atrophy (especially ...

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.